BATON ROUGE – Visitors across the country are wondering why Dsuvia is needed. This new opioid analgesic recently got the stamp of approval by the FDA, but many agree and think it is a terrible mistake.
"We are in the midst of the worst epidemic, an epidemic of opioids in this country that will probably kill and hurt more than any other epidemic from the country, or the world has seen," said coroner Bau Clark.
East Baton Rouge Parish Coroner, Dr.Beau Clark saw first-hand the deadly effects of opioid use with at least 72 overdose deaths in the community alone this year.
"It looks like a blatant disregard for human life, we're talking about substance, opioids kill people, why do we need more when we have a problem with what we have," Clark said.
According to the FDA, there are strict guidelines for the drug that dissolves in the mouth. It can only be used in hospitals, surgical centers, and emergency rooms. Dsuvia should not be used for more than 72 hours, and it is not available in retail pharmacies.
They say it is a cure that will be administered only in a health facility for a very short period of time in a very controlled environment. This is great if this is the case. However, later in the statement, they say it was also developed with the Ministry of Defense, so it also contradicts itself.
"This opioid formulation, together with Dsuvia's unique delivery device, was a superior product over the Pentagon medium because it fulfills a specific but insignificant need but is limited to the need to treat our nation's soldiers," said Dr. Scott Gottlieb. But Dr. Clark does not buy it.
"A soldier is there to defend our country, and if they are injured on the battlefield we need mechanisms to manage their pain especially if they have long transport time from where they are suffering final treatment but I think these things already exist," Clark said.
Serious risks of using Dsuvia include respiratory depression, coma, and even death not to mention the highly addictive quality.
"Having stronger and stronger opioids is really the wrong direction and certainly sends the wrong message." "We do not avoid what I believe to be the real source of dissatisfaction among critics of this confirmation of whether or not America needs a powerful opioid while it is in the midst of a massive crisis of addiction," Dr. Gottlieb said of Desovia.
Gottlieb says the question will be handled openly and directly. Dsuvia is expected to bring 1.1 billion in annual sales, but for Clark, he is more concerned with life that can be lost in the future.
"We are on track for another record year of increasing the number of opioids compared to even last year, and I do not see an end in sight, and when we do something like that, and we create another category of even stronger opioid I think it leads to more and more problems," Clark said.
For more information on Dswvia, click here.